Patents by Inventor Jérôme Wojcik

Jérôme Wojcik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
    Patent number: 10703798
    Abstract: Fusion polypeptides have an FGFR2 polypeptide and cDNAs encode such fusion polypeptides. Methods of diagnosing the presence of the fusion polypeptides or of a gene or RNA sequence coding therefore in a sample from a subject as well as methods of treatment of a tumor instructed by the latter diagnosis.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: July 7, 2020
    Assignee: DEBIOPHARM INTERNATIONAL SA
    Inventors: Hiroaki Tanaka, Corinne Moulon, Anne Vaslin Chessex, Jérôme Wojcik, Claudia Armenise
  • FGFR FUSIONS
    Publication number: 20170107271
    Abstract: Fusion polypeptides have an FGFR2 polypeptide and cDNAs encode such fusion polypeptides. Methods of diagnosing the presence of the fusion polypeptides or of a gene or RNA sequence coding therefore in a sample from a subject as well as methods of treatment of a tumor instructed by the latter diagnosis.
    Type: Application
    Filed: March 31, 2015
    Publication date: April 20, 2017
    Applicant: DEBIOPHARM INTERNATIONAL SA
    Inventors: Hiroaki TANAKA, Corinne MOULON, Anne Vaslin CHESSEX, Jérôme WOJCIK, Claudia ARMENISE
  • GENETIC SEVERITY MARKERS IN MULTIPLE SCLEROSIS
    Publication number: 20120003182
    Abstract: The present invention relates to the use of SNPs in predicting susceptibility and/or severity of Multiple Sclerosis in an individual. The SNPs are located in the introns of the glycosylation enzymes MGAT5 and XYLT1, 3? of HIF1AN, within introns of MEGF11. FGF14, PDE9A and CDH13 and within desert regions of 4q34 and 17p13.
    Type: Application
    Filed: March 25, 2010
    Publication date: January 5, 2012
    Applicant: MERCK SERONO SA
    Inventors: Hadi Abderrahim, Jérôme Wojcik, Federica Esposito, Virginie Debailleul
  • BANK1 RELATED SNPS AND SLE AND/OR MS SUSCEPTIBILITY
    Publication number: 20110319288
    Abstract: The invention relates to a method of genotyping and for predicting the susceptibility for SLE and/or MS by using SNPs related to BANK1 alone or in combination with at least one other SNP.
    Type: Application
    Filed: March 1, 2010
    Publication date: December 29, 2011
    Applicant: MERCK SERONO S.A.
    Inventors: Jérôme Wojcik, Marta Alarcôn-Riquelme, Casimiro Castillejo-López